Therefore, suppression of EGR-1 and CYP19 aromatase expression by dietary chrysoeriol in the breast tumor microenvironment may be beneficial as a preventive agent or as a chemotherapeutic adjuvant against estrogen receptor-positive breast cancer. Here, EGR1 is linked to breast neoplasm.